| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Seok-geun Yoon CEO | KRX SM Exchange | KR7003120003 ISIN |
| South Korea Country | - Employees | 29 Dec 2025 Last Dividend | 17 Apr 2023 Last Split | - IPO Date |
Ilsung Is Co., Ltd. is a pharmaceutical company based in Seoul, South Korea, with a long-standing legacy dating back to 1954. Initially known as Ilsung Pharmaceuticals Co., Ltd., the company transitioned to Ilsung Is Co., Ltd. in April 2024, reflecting its evolution and expansion in the pharmaceutical industry. Over the decades, Ilsung Is Co., Ltd. has established itself as a key player in the South Korean pharmaceutical market, specializing in the development, production, and distribution of a wide array of pharmaceutical products and medical equipment.
Ilsung Is Co., Ltd. offers an extensive portfolio of pharmaceutical products and medical equipment catering to various medical needs and conditions: